文献速递肿瘤 PET/CT放射性药物与辐射防护

FDG PET/CT 诊断有暴露史但症状轻微癌症患者的 COVID-19 感染

FDG PET/CT in Diagnosing COVID-19 Infection in a Cancer Patient With Exposure History But Minimal Symptoms.
PubMed 文献 · Clin Nucl Med · 2020-01-01

一例 56 岁高级别神经内分泌小细胞癌女性,在再分期 PET/CT 前约 16 天有 COVID-19 接触史,自我隔离 14 天且未做 COVID-19 检测。到达时低热 37.1°C,不符合 COVID-19 检测的感染控制标准,获准进行 PET/CT。FDG PET/CT 显示新发多灶性高代谢双侧肺磨玻璃影,提示 COVID-19 肺炎;患者症状随后加重,血液检测 later 证实 COVID-19 感染。

要点

  • 有 COVID-19 接触史但症状轻微的癌症患者,FDG PET/CT 可显示提示 COVID-19 肺炎的双侧肺磨玻璃影。
  • 该患者低热 37.1°C 但不符合感染控制标准,仍获准进行 PET/CT。
  • FDG PET/CT 发现新发多灶性高代谢双侧肺磨玻璃影后,患者症状加重,血液检测证实 COVID-19 感染。

核心结论

  • FDG PET/CT 发现新发多灶性高代谢双侧肺磨玻璃影,提示 COVID-19 肺炎,随后血液检测证实 COVID-19 感染。

研究设计与样本

  • 病例报告:一例 56 岁高级别神经内分泌小细胞癌女性,在再分期 PET/CT 前约 16 天有 COVID-19 接触史。

主要发现

  • 患者自我隔离 14 天,未进行 COVID-19 检测;到达时低热 37.1°C,不符合 COVID-19 检测的感染控制标准,获准进行 PET/CT。
  • FDG PET/CT 显示新发多灶性高代谢双侧肺磨玻璃影,提示 COVID-19 肺炎。
  • 患者症状随后加重,血液检测 later 证实 COVID-19 感染。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

A 56-year-old woman with high-grade neuroendocrine small cell carcinoma had known contact history of COVID-19 about 16 days prior to the restaging PET/CT. The patient was instructed to self-quarantine for 14 days, and no COVID-19 test was performed. Upon arrival, the patient had low-grade fever of 37.1°C, but did not meet infection control criteria for COVID-19 testing, and it was approved to proceed with PET/CT. The FDG PET/CT images revealed new multifocal hypermetabolic bilateral pulmonary ground-glass opacities that are suggestive of COVID-19 pneumonia. Meanwhile, the patient's symptoms worsened, and a blood test later confirmed COVID-19 infection.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Chuang HH, Emery DJ, Campbell RM, et al. FDG PET/CT in Diagnosing COVID-19 Infection in a Cancer Patient With Exposure History But Minimal Symptoms. Clin Nucl Med. 2020. PMID: 32433162. doi:10.1097/RLU.0000000000003137

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。